Marcelo Capra, Gurdeep Parmar, Fernanda Seguro, Vania Hungria, Meletios A. Dimopoulos, Sosana Delimpasi, Junichiro Yuda, Ivan Špička, Roman Hajek, Christine Soufflet, Disa Yu, Victorine Koch, Florence Suzan, Jiri Minarik, Hang Quach. "Updated results from the phase 2 IZALCO study: Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7564